Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01812447 · ClinicalTrials.gov registry record · NA
Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function
A NA study, sponsored by Olympus Corporation of the Americas.
- Completed
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT01812447 is a NA study that has completed, run by Olympus Corporation of the Americas. The registered enrollment target is 172 participants.
The verdict
NCT01812447, a NA study, has completed, sponsored by Olympus Corporation of the Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
EMPROVE is a multicenter, prospective, randomized, controlled study designed to evaluate the safety and long-term effectiveness of the Spiration Valve System in patients with emphysema. Patients appropriate for the EMPROVE study are those who are currently on medical treatment but still symptomatic. EMPROVE also accepts α-1 antitrypsin deficiency patients.
Interventions
- OTHER Medical Management
- DEVICE Spiration Valve System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2013-06 |
| Est. Completion | 2022-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01812447
The ClinicalTrials.gov registry entry for NCT01812447 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olympus Corporation of the Americas, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medical Management is the first listed.
NCT01812447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01812447 about?
NCT01812447 is a clinical study titled "Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function". EMPROVE is a multicenter, prospective, randomized, controlled study designed to evaluate the safety and long-term effectiveness of the Spiration Valve System in patients with emphysema. Patients appropriate for the EMPROVE study are those who are currently on medical treatment but still symptomatic...
What is the current status of trial NCT01812447?
This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2013-06. Estimated completion is 2022-08.
What interventions are being tested in trial NCT01812447?
The interventions under investigation include: Medical Management (OTHER), Spiration Valve System (DEVICE).
Who is sponsoring clinical trial NCT01812447?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.